Anatomy of a Freedom-to-Operate Search That Saved a Client Millions

Most legal work is invisible until it isn't. Nobody throws a party when a lawsuit doesn't happen. But every so often, a quiet, unglamorous piece of due diligence turns out to be the single most valuable thing a company did all year. Freedom-to-operate searches are usually exactly that kind of work; until you look closely at one and realize how much was riding on it.

Here's what one of these searches actually looks like from the inside, why it matters so much more than people expect, and what happens to companies that skip it.

First, what "freedom to operate" actually means

A freedom-to-operate search, FTO for short, is not the same thing as a patentability search. A patentability search asks, "Can I get a patent on this?" An FTO search asks a completely different, much scarier question: "Even if my invention is novel, am I about to walk into someone else's patent fence and get sued for it?"

You can absolutely invent something new and patentable that still infringes an existing patent. Novelty and freedom to operate are separate axes. A company can hold its own valid patent on a product and still be barred from making, using, selling, or importing that product because a component of it falls inside someone else's claims. This trips people up constantly, including founders who assume that because their legal team filed a patent, they're in the clear.

An FTO search maps the live patent landscape around a specific product, in specific countries, at a specific point in time, and asks whether any unexpired, in-force claims would cover what the client is about to build or sell. It's narrower than a general patent search and far more consequential, because the output isn't academic. It directly determines whether a product launches, gets redesigned, or gets licensed.

The case: a medical device company staring down a launch date

To make this concrete, picture a mid-sized medical device company, call the situation representative of the kind FTO teams handle every week, because the shape of it repeats constantly across industries. The company had spent three years and a substantial R&D budget developing a next-generation drug-delivery device: a wearable injector with a novel dosing mechanism. Manufacturing tooling was booked. A distribution deal was signed. Marketing had a launch date circled on the calendar. And almost as an afterthought, someone in legal asked: "Did we ever run a proper FTO on the final design?"

They hadn't. Early in development, someone had done a quick patentability check to confirm the dosing mechanism was novel enough to file on. That search told them what they could patent. It never told them whose patents they might be infringing. Those are different questions answered by different searches, and conflating them is one of the most common and most expensive mistakes in product development.

This is precisely the trap described in industry case studies of companies that lean on a patentability search all the way through development and only run an FTO right before commercialization, by which point millions have already been spent and canceling the launch is no longer a real option.

Step one: scoping, before a single patent gets read

A good FTO search doesn't start with a database query. It starts with a scoping conversation that's more interrogation than meeting. What, precisely, is the product? Not the marketing description, the engineering reality. What are its components, subsystems, and methods of use? Which countries will it actually be sold in, since patent rights are territorial and a clearance in the U.S. means nothing in Germany? What's the timeline, since the search has to account for applications that are pending but not yet granted, which can still turn into live claims later?

For the injector, this meant breaking the device into its constituent parts: the spring-loaded actuation mechanism, the dose-setting dial, the skin-sensor that triggered injection, the cartridge interface, and the software that logged dosing data to a companion app. Each of those is a separate technology area with its own patent landscape, and treating the product as a single monolithic "thing" to search is how teams miss the claim that actually matters.

Step two: building the claim landscape

With scope defined, the search itself begins and it's less like Googling and more like archaeology. Patent databases were queried using classification codes, keyword strings, and citation trees (patents that cite each other tend to cluster around the same technical problem, which is often the fastest way to find the family of patents you actually need to worry about). Competitor portfolios were pulled directly, since the companies most likely to hold a blocking patent are usually the ones already active in the same space.

For the injector, this turned up roughly 350 patents and published applications touching drug-delivery devices, wearable injectors, or dose-metering mechanisms. Most of those were irrelevant on inspection & expired, narrowly drawn to unrelated mechanisms, or covering territories the client didn't care about. That's normal. The vast majority of an FTO search is elimination, not discovery. The skill is in not stopping the elimination process too early.

Step three: claim charting, where the real work happens

This is the part that separates a rigorous FTO from a box-checking exercise. For every patent that survived the initial cull, the independent claims were broken down element by element and mapped directly against the client's device, literally feature by feature, in a chart. Not "does this patent feel similar," but "does every single element of claim 1 read onto something the device actually does." Patent infringement in most jurisdictions requires that all elements of a claim be present; missing even one element is often enough to avoid infringement.

Out of 350 patents, this narrowed things to 10 that warranted serious claim charting, and out of those 10, one stood out as a real problem: a patent held by a competitor, granted four years earlier, with a broad independent claim covering a skin-contact sensor that automatically triggered dose delivery upon detecting proper device placement. The client's injector did almost exactly that.

This is the moment an FTO search either saves a company or fails to. A shallow search would have flagged this patent as "related" and moved on, or worse, missed it entirely because the patent's title referenced a completely different product category (it had originally been filed for a different type of medical device and only later become broadly relevant as wearable injectors caught up to the technology). Patents don't always announce their relevance in the title. Finding this one required reading claim language literally, not skimming abstracts.

Step four: figuring out what to actually do about it

Finding a blocking patent isn't the end of an FTO search. It's the point where the real strategic work starts. The team laid out the standard menu of options: challenge the patent's validity (expensive, slow, and never a sure thing), negotiate a license (possible, but it hands leverage to a competitor who now knows exactly how much the client needs this feature), or design around the claim entirely.

A validity search on the blocking patent turned up prior art that made an invalidity challenge plausible but far from guaranteed; not the kind of thing you want to bet a product launch on. Licensing was explored quietly through an intermediary, and the competitor's initial signals suggested they had no interest in licensing to a direct rival in the same device category.

That left design-around as the realistic path. The engineering team and the patent attorneys worked together. This part only works when lawyers and engineers are in the same room, not passing memos back and forth to figure out whether the sensor mechanism could be modified to fall outside the claim's scope while still functioning. The blocking claim specifically required detecting skin contact and automatically triggering delivery based on that detection. The team redesigned the mechanism so the skin sensor confirmed placement but required a separate, independent activation input from the user. A small mechanical change, but one that removed the automatic-trigger element the claim depended on. A second claim chart confirmed the redesigned mechanism no longer read onto the patent.

Step five: the second search

Here's the part that gets skipped by teams in a hurry, and it's the part that makes the difference between a real FTO and a paper exercise: after the redesign, the search wasn't just declared clear. The modified mechanism was run back through the same claim-charting process against the full set of surviving patents, because a design-around can just as easily wander into a different patent's claims. It didn't, in this case, but confirming that took another two weeks nobody had budgeted for, and skipping it is exactly how companies think they've solved a problem and haven't.

What it actually saved them

The device launched roughly six weeks later than originally planned. Six weeks, against a three-year development cycle and a distribution deal already signed, is close to nothing. Compare that to what the alternative looks like.

The textbook cautionary tale here, and one worth sitting with, is Research In Motion and its BlackBerry. RIM built its wireless email business without securing rights to patents held by a small Virginia firm called NTP. NTP had approached RIM about licensing its technology back in 2000 and reportedly didn't get a response. The dispute dragged on for six years, went all the way to the Supreme Court, and at one point genuinely threatened to shut down BlackBerry service for millions of U.S. users, prompting a federal judge to openly question RIM's rationality for not settling sooner. RIM ultimately paid NTP $612.5 million in 2006 to end it, on top of years of legal fees, a stock price whipsawed by litigation uncertainty, and, by the company's own admission, tens of thousands of subscribers it lost simply because customers got nervous about buying a product that might get switched off by a court order.

That's the shape of what a missing or shallow FTO search actually costs: not just a settlement number, but years of distraction, a wounded brand, and a competitor who got to dictate terms because they held the leverage. The injector company's redesign, licensing negotiation, and six-week delay look almost trivial by comparison, and that gap between "mildly annoying" and "existential," is the entire value proposition of doing this work properly and early.

It's worth noting this instinct isn't new. Thomas Edison, working on the incandescent light bulb, searched existing patents and found that an earlier filing by two Canadian inventors, Henry Woodward and Mathew Evans, covered carbon filaments sealed in a non-oxidized environment, uncomfortably close to what he was working on. Rather than risk a fight, he simply licensed the patent. It's a small, old story, but it's the same logic that ran through the injector case a century and change later: find the obstacle before you build a business on top of it, not after.

The lessons that generalize

A few things about this kind of search hold true regardless of industry:

Timing is everything, and later is always worse. An FTO run during early design, when a mechanism can still be changed on a whiteboard, is a routine engineering conversation. The same FTO run after tooling is bought and a launch date is public is a crisis. The cost of the search itself barely moves; the cost of acting on what it finds goes up by orders of magnitude the closer you get to market.

Claim charting has to be literal, not impressionistic. The patent that nearly derailed the injector didn't look dangerous from its title or abstract. It looked dangerous when someone sat down and mapped its claim elements against the actual device, one by one. Search reports that summarize "similar patents" without doing that element-by-element work are giving a false sense of security.

Lawyers and engineers need to solve the problem together. A design-around isn't a legal memo; it's an engineering change that has to actually work, manufacture reliably, and not quietly infringe a different patent on the way past. That only happens when both sides are in the room from the moment a blocking patent turns up, not after.

And finally, a clean initial search result isn't the finish line if anything about the product changes afterward. Redesigns need to be re-cleared. The instinct to treat FTO as a one-time stamp of approval, rather than a check that has to be repeated whenever the product moves, is exactly how "we already did an FTO" turns into a very expensive sentence a few years later.

None of this makes for a dramatic story in the moment. There's no verdict, no headline, no dramatic courtroom scene. Just a patent attorney and a design engineer, staring at a claim chart, quietly redesigning a sensor so it does almost the same thing in a slightly different way, and a company that never finds out what it would have cost them not to.

#FreedomToOperate #PatentSearch #IPStrategy #IntellectualProperty #ProductDevelopment #RiskManagement #BooleanIPConsulting